THL Equity Fund VII Investors (inVentiv), L.P., Director at Syneos Health, Inc. (SYNH), sold 759,667 shares at $81.04 ($61.6M) on 2021-05-12, disclosed to the SEC on 2021-05-20.
Open-market sale of $61.6M SYNH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $81.04 | 25 | $2K | 0.0% |
| 2 | $81.04 | 64 | $5K | 0.0% |
| 3 | $81.04 | 379,789 | $30.8M | 50.0% |
| 4 | $81.04 | 379,789 | $30.8M | 50.0% |
| Total | $81.04 avg | 759,667 | $61.6M | 100% |